Cadence Bank NA’s AstraZeneca AZN Stock Holding History

Cadence Bank NA’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,401	Closed	-$288K	–	215
2021 Q3	$288K	Sell	2,401 -245	-9%	-$28.5K	0.09%	176
2021 Q2	$317K	Buy	+2,646	New	+$290K	0.09%	167

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cadence Bank NA's AZN Position: Q4 2021 in Review

Cadence Bank NA sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 2,401 shares — an estimated $288K sold.

Cadence Bank NA first reported a position in AZN in Q2 2021 and held it in 2 quarters. The position peaked at $317K in Q2 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

Cadence Bank NA reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
Cadence Bank NA sold 2,401 AstraZeneca shares in Q4 2021, an estimated $288K.
Cadence Bank NA first reported a position in AstraZeneca in Q2 2021 and held it in 2 quarters.
Cadence Bank NA's AstraZeneca position peaked at $317K in Q2 2021.
949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Cadence Bank NA's 13F filing for Q4 2021, filed 19 Jan 2022.